[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 049″]
Oculeve’s stunning acquisition by Allergan last week led us back to a conversation we had with Mark S. Blumenkranz, MD, Professor & Chairman of the Department of Ophthalmology, Stanford University. Mark S. Blumenkranz is the H.J. Smead Professor and Chairman of the Department of Ophthalmology at Stanford University. He received his Baccalaureate, Master of Medical Science, and MD degrees at Brown University, followed by a Residency in Ophthalmology at Stanford. Dr. Blumenkranz is a noted vitreoretinal surgeon who served as Co-Director of the Retinal Service at Stanford for five years prior to assuming the Chairmanship in November 1997.
Mark S. Blumenkranz, MD
Mark S. Blumenkranz, MD, MMS, is HJ Smead Professor in the Department of Ophthalmology at Stanford University. He received his undergraduate, graduate degree in biochemical pharmacology, and medical education at Brown University.